Status:
COMPLETED
Bioequivalence of Eye Drops and Spray Administration of Vigamox
Lead Sponsor:
Advanced Ophthalmic Pharma
Conditions:
Cataract
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueou...
Eligibility Criteria
Inclusion
- Patients scheduled for elective cataract surgery
Exclusion
- Allergy to Vigamox
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00666042
Start Date
February 1 2009
End Date
May 1 2009
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Ophthalmology, TAMC
Tel Aviv, Israel, 69089